In conclusion, Ecad+ EVs and CD45+ EVs, respectively, derived from epithelial cells and immune cells, constituted a minor fraction (11%, Figure 3B) of thyroid tissue-derived CD9+/CD81+ EV pool, but showed a doubling in their proportion within the total EV pool of tumor tissue (23%, Figure 3B). This evidence concerns the gene CD81 and neoplasm.